Dr. Sudhir Srivastava on Expanding Cancer Care Through Indigenous Robotics

SSI Mantra 3 Credits: Press release

On the occasion of World Cancer Day, Dr. Sudhir Srivastava highlighted the growing impact of indigenous surgical robotics in transforming cancer care in India. He emphasised that by improving surgical precision, clinical outcomes, and—most importantly—access to advanced treatment beyond metropolitan centres, homegrown innovation is reshaping the country’s oncology landscape.

Addressing One of Healthcare’s Most Complex Challenges

Cancer remains one of the most complex healthcare challenges worldwide, demanding not only medical excellence but also timely and equitable access to care. As surgical oncology continues to evolve, robotic-assisted surgery is gaining wider adoption for its ability to enhance surgical accuracy, minimise trauma, and support faster recovery. Consequently, these advancements play a critical role in improving patient outcomes and overall quality of life.

Expanding Access Beyond Metropolitan Centres

As per the press release, speaking on the importance of accessibility in cancer treatment, Dr. Sudhir Srivastava, Founder, Chairman & CEO, SS Innovations International Inc., said that cancer affects not only patients but entire families. He noted that the treatment journey depends as much on trust and timely access as it does on clinical precision.

Also Read |  Spike in Foot and Ankle Injuries Alarms Doctors

Dr. Srivastava explained that robotic-assisted surgery significantly improves cancer care by enabling greater accuracy, reducing surgical trauma, and supporting quicker recovery. However, he stressed that access remains a key challenge, particularly in a country like India, where advanced surgical care has traditionally been concentrated in a few metropolitan hospitals. As a result, patients from smaller cities often face delays that can adversely affect outcomes.

Driving Equitable Care Through Made-in-India Innovation

Addressing this gap, Dr. Srivastava said SS Innovations is actively changing the landscape by developing affordable, Made-in-India surgical robotic systems. Today, a majority of the company’s installations operate in Tier II and Tier III cities, bringing advanced, precision-led cancer care closer to patients’ homes.

Through this approach, SS Innovations is helping ensure that high-quality surgical oncology is no longer limited by geography. Instead, patients across the country can access advanced treatment without the added burden of travel to distant urban centres.

Innovation and Inclusivity Must Go Hand in Hand

Also Read |  India Launches AI-Driven Pregnancy Study Under GARBH-INi to Predict Preterm Births

Dr. Srivastava further emphasised that World Cancer Day serves as a powerful reminder that innovation must progress alongside inclusivity. Indigenous medical technology, particularly in surgical robotics, holds the potential to bridge the long-standing gap between clinical excellence and affordability. By doing so, it can ensure that advanced cancer care reaches a broader population and becomes a more equitable reality across India.